Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Novel silicon-containing cannabinoids show therapeutic efficacy in model of multiple sclerosis

Nov. 29, 2021

KCC2 shows promise as therapeutic target for neonatal seizures

Nov. 29, 2021

U.S. researchers patent TREM2 agonists

Nov. 29, 2021

Eli Lilly divulges new MRGPRX1 agonists

Nov. 29, 2021

Takeda Pharmaceutical presents new ABCC2 inhibitors

Nov. 26, 2021

PCC-0105002 attenuates neuropathic pain without motor coordination-associated side effects

Nov. 25, 2021

New Bcl-2 inhibitors discovered at Prelude Therapeutics

Nov. 25, 2021

Adenosine A1R/A3R agonist AST-004 ameliorates brain infarction in an NHP model of stroke

Nov. 25, 2021

RaQualia Pharma synthesizes new TRPV4 antagonists

Nov. 24, 2021

Preclinical Alzheimer's vaccine, therapy target soluble amyloid

Nov. 24, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 19, 2026.
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
Authorities work to quickly sequence Ebola species in latest outbreak
BioWorld
If the recent hantavirus outbreak wasn’t enough to keep public health officials busy, a new Ebola virus disease outbreak has been confirmed by authorities in the...
Camp4 studies CMP-002 in SYNGAP1 haploinsufficient mouse model
BioWorld Science
Camp4 Therapeutics Corp. has highlighted new preclinical data for CMP-002, the company’s lead investigational antisense oligonucleotide (ASO) therapeutic...